Lenzilumab blocks GM-CSF, stopping creation of ne
Post# of 148190
(Total Views: 650)
Posted On: 07/30/2020 11:35:40 AM
Lenzilumab blocks GM-CSF, stopping creation of new macrophages, eosinophils and basophils, which in an already over stimulated/dysregulated immune response is injurious.
Leronlimab blocks trafficking of inflammatory white blood cells to areas of inflammation, restores some of these same cells to a normal infection fighting, rather than inflammatory state, and restores ability of immune system to fight the virus.
Lenzilumab can mitigate the cytokine storm, but pales in comparison to leronlimab.
I implore you to read Dr. Patterson’s manuscript on RANTES, Covid and leronlimab and/or watch his TED talk.
Leronlimab blocks trafficking of inflammatory white blood cells to areas of inflammation, restores some of these same cells to a normal infection fighting, rather than inflammatory state, and restores ability of immune system to fight the virus.
Lenzilumab can mitigate the cytokine storm, but pales in comparison to leronlimab.
I implore you to read Dr. Patterson’s manuscript on RANTES, Covid and leronlimab and/or watch his TED talk.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼